1
|
Li D, Farrell JJ, Mez J, Martin ER, Bush WS, Ruiz A, Boada M, de Rojas I, Mayeux R, Haines JL, Vance MAP, Wang LS, Schellenberg GD, Lunetta KL, Farrer LA. Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. Alzheimers Dement 2023; 19:5550-5562. [PMID: 37260021 PMCID: PMC10689571 DOI: 10.1002/alz.13117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Revised: 03/29/2023] [Accepted: 04/11/2023] [Indexed: 06/02/2023]
Abstract
INTRODUCTION Most Alzheimer's disease (AD) loci have been discovered in individuals with European ancestry (EA). METHODS We applied principal component analysis using Gaussian mixture models and an Ashkenazi Jewish (AJ) reference genome-wide association study (GWAS) data set to identify Ashkenazi Jews ascertained in GWAS (n = 42,682), whole genome sequencing (WGS, n = 16,815), and whole exome sequencing (WES, n = 20,504) data sets. The association of AD was tested genome wide (GW) in the GWAS and WGS data sets and exome wide (EW) in all three data sets (EW). Gene-based analyses were performed using aggregated rare variants. RESULTS In addition to apolipoprotein E (APOE), GW analyses (1355 cases and 1661 controls) revealed associations with TREM2 R47H (p = 9.66 × 10-9 ), rs541586606 near RAB3B (p = 5.01 × 10-8 ), and rs760573036 between SPOCK3 and ANXA10 (p = 6.32 × 10-8 ). In EW analyses (1504 cases and 2047 controls), study-wide significant association was observed with rs1003710 near SMAP2 (p = 1.91 × 10-7 ). A significant gene-based association was identified with GIPR (p = 7.34 × 10-7 ). DISCUSSION Our results highlight the efficacy of founder populations for AD genetic studies.
Collapse
Affiliation(s)
- Donghe Li
- Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
| | - John J Farrell
- Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
| | - Jesse Mez
- Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
| | - Eden R. Martin
- Dr. John T. Macdonald Foundation, University of Miami, Miami, FL 33136, USA
- Department of Human Genetics, University of Miami, Miami, FL 33136, USA
| | - William S. Bush
- Department of Population & Quantitative Health Science and Cleveland Institute for Computational Biology, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA
| | - Agustin Ruiz
- Research Center and Memory Clinic, ACE Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain
- CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
| | - Mercè Boada
- Research Center and Memory Clinic, ACE Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain
- CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
| | - Itziar de Rojas
- Research Center and Memory Clinic, ACE Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain
- CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
| | - Richard Mayeux
- Taub Institute on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center Department of Neurology, Columbia University, 710 West 168th Street, New York, NY 10032, USA
| | - Jonathan L. Haines
- Department of Population & Quantitative Health Science and Cleveland Institute for Computational Biology, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA
| | - Margaret A. Pericak Vance
- Dr. John T. Macdonald Foundation, University of Miami, Miami, FL 33136, USA
- Department of Human Genetics, University of Miami, Miami, FL 33136, USA
- Department of Neurology, University of Miami, Miami, FL 33136, USA
| | - Li-San Wang
- Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
| | - Gerard D. Schellenberg
- Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
| | - Kathryn L. Lunetta
- Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA
| | - Lindsay A. Farrer
- Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
- Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
- Department of Ophthalmology, Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA
- Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
| |
Collapse
|
2
|
Wang KW, Yuan YX, Zhu B, Zhang Y, Wei YF, Meng FS, Zhang S, Wang JX, Zhou JY. X chromosome-wide association study of quantitative biomarkers from the Alzheimer's Disease Neuroimaging Initiative study. Front Aging Neurosci 2023; 15:1277731. [PMID: 38035272 PMCID: PMC10682795 DOI: 10.3389/fnagi.2023.1277731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Accepted: 10/20/2023] [Indexed: 12/02/2023] Open
Abstract
Introduction Alzheimer's disease (AD) is a complex neurodegenerative disease with high heritability. Compared to autosomes, a higher proportion of disorder-associated genes on X chromosome are expressed in the brain. However, only a few studies focused on the identification of the susceptibility loci for AD on X chromosome. Methods Using the data from the Alzheimer's Disease Neuroimaging Initiative Study, we conducted an X chromosome-wide association study between 16 AD quantitative biomarkers and 19,692 single nucleotide polymorphisms (SNPs) based on both the cross-sectional and longitudinal studies. Results We identified 15 SNPs statistically significantly associated with different quantitative biomarkers of the AD. For the cross-sectional study, six SNPs (rs5927116, rs4596772, rs5929538, rs2213488, rs5920524, and rs5945306) are located in or near to six genes DMD, TBX22, LOC101928437, TENM1, SPANXN1, and ZFP92, which have been reported to be associated with schizophrenia or neuropsychiatric diseases in literature. For the longitudinal study, four SNPs (rs4829868, rs5931111, rs6540385, and rs763320) are included in or near to two genes RAC1P4 and AFF2, which have been demonstrated to be associated with brain development or intellectual disability in literature, while the functional annotations of other five novel SNPs (rs12157031, rs428303, rs5953487, rs10284107, and rs5955016) have not been found. Discussion 15 SNPs were found statistically significantly associated with the quantitative biomarkers of the AD. Follow-up study in molecular genetics is needed to verify whether they are indeed related to AD. The findings in this article expand our understanding of the role of the X chromosome in exploring disease susceptibility, introduce new insights into the molecular genetics behind the AD, and may provide a mechanistic clue to further AD-related studies.
Collapse
Affiliation(s)
- Kai-Wen Wang
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | - Yu-Xin Yuan
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | - Bin Zhu
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | - Yi Zhang
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | - Yi-Fang Wei
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | - Fan-Shuo Meng
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | - Shun Zhang
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
| | - Jing-Xuan Wang
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
| | - Ji-Yuan Zhou
- State Key Laboratory of Organ Failure Research, Ministry of Education, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China
- Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China
| | | |
Collapse
|
3
|
Adamu MJ, Qiang L, Nyatega CO, Younis A, Kawuwa HB, Jabire AH, Saminu S. Unraveling the pathophysiology of schizophrenia: insights from structural magnetic resonance imaging studies. Front Psychiatry 2023; 14:1188603. [PMID: 37275974 PMCID: PMC10236951 DOI: 10.3389/fpsyt.2023.1188603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Accepted: 04/20/2023] [Indexed: 06/07/2023] Open
Abstract
Background Schizophrenia affects about 1% of the global population. In addition to the complex etiology, linking this illness to genetic, environmental, and neurobiological factors, the dynamic experiences associated with this disease, such as experiences of delusions, hallucinations, disorganized thinking, and abnormal behaviors, limit neurological consensuses regarding mechanisms underlying this disease. Methods In this study, we recruited 72 patients with schizophrenia and 74 healthy individuals matched by age and sex to investigate the structural brain changes that may serve as prognostic biomarkers, indicating evidence of neural dysfunction underlying schizophrenia and subsequent cognitive and behavioral deficits. We used voxel-based morphometry (VBM) to determine these changes in the three tissue structures: the gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). For both image processing and statistical analysis, we used statistical parametric mapping (SPM). Results Our results show that patients with schizophrenia exhibited a significant volume reduction in both GM and WM. In particular, GM volume reductions were more evident in the frontal, temporal, limbic, and parietal lobe, similarly the WM volume reductions were predominantly in the frontal, temporal, and limbic lobe. In addition, patients with schizophrenia demonstrated a significant increase in the CSF volume in the left third and lateral ventricle regions. Conclusion This VBM study supports existing research showing that schizophrenia is associated with alterations in brain structure, including gray and white matter, and cerebrospinal fluid volume. These findings provide insights into the neurobiology of schizophrenia and may inform the development of more effective diagnostic and therapeutic approaches.
Collapse
Affiliation(s)
- Mohammed Jajere Adamu
- Department of Electronic Science and Technology, School of Microelectronics, Tianjin University, Tianjin, China
- Department of Computer Science, Yobe State University, Damaturu, Nigeria
| | - Li Qiang
- Department of Electronic Science and Technology, School of Microelectronics, Tianjin University, Tianjin, China
| | - Charles Okanda Nyatega
- Department of Information and Communication Engineering, School of Electrical and Information Engineering, Tianjin University, Tianjin, China
- Department of Electronics and Telecommunication Engineering, Mbeya University of Science and Technology, Mbeya, Tanzania
| | - Ayesha Younis
- Department of Electronic Science and Technology, School of Microelectronics, Tianjin University, Tianjin, China
| | - Halima Bello Kawuwa
- Department of Biomedical Engineering and Scientific Instruments, School of Precision Instruments and Optoelectronics Engineering, Tianjin University, Tianjin, China
| | - Adamu Halilu Jabire
- Department of Electrical and Electronics Engineering, Taraba State University, Jalingo, Nigeria
| | - Sani Saminu
- Department of Biomedical Engineering, University of Ilorin, Ilorin, Nigeria
| |
Collapse
|
4
|
Li N, Ma W, Ren F, Li X, Li F, Zong W, Wu L, Dai Z, Hui SCN, Edden RAE, Li M, Gao F. Neurochemical and functional reorganization of the cognitive-ear link underlies cognitive impairment in presbycusis. Neuroimage 2023; 268:119861. [PMID: 36610677 PMCID: PMC10026366 DOI: 10.1016/j.neuroimage.2023.119861] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2022] [Revised: 12/11/2022] [Accepted: 01/03/2023] [Indexed: 01/06/2023] Open
Abstract
Recent studies suggest that the interaction between presbycusis and cognitive impairment may be partially explained by the cognitive-ear link. However, the underlying neurophysiological mechanisms remain largely unknown. In this study, we combined magnetic resonance spectroscopy (MRS) and resting-state functional magnetic resonance imaging (fMRI) to investigate auditory gamma-aminobutyric acid (GABA) and glutamate (Glu) levels, intra- and inter-network functional connectivity, and their relationships with auditory and cognitive function in 51 presbycusis patients and 51 well-matched healthy controls. Our results confirmed reorganization of the cognitive-ear link in presbycusis, including decreased auditory GABA and Glu levels and aberrant functional connectivity involving auditory networks (AN) and cognitive-related networks, which were associated with reduced speech perception or cognitive impairment. Moreover, mediation analyses revealed that decreased auditory GABA levels and dysconnectivity between the AN and default mode network (DMN) mediated the association between hearing loss and impaired information processing speed in presbycusis. These findings highlight the importance of AN-DMN dysconnectivity in cognitive-ear link reorganization leading to cognitive impairment, and hearing loss may drive reorganization via decreased auditory GABA levels. Modulation of GABA neurotransmission may lead to new treatment strategies for cognitive impairment in presbycusis patients.
Collapse
Affiliation(s)
- Ning Li
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Wen Ma
- Department of Otolaryngology, the Central Hospital of Jinan City, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Fuxin Ren
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Radiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Xiao Li
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Radiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Fuyan Li
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Radiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Wei Zong
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Radiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Lili Wu
- CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China
| | - Zongrui Dai
- Westa College, Southwest University, Chongqing, China
| | - Steve C N Hui
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA
| | - Richard A E Edden
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA
| | - Muwei Li
- Vanderbilt University Institute of Imaging Science, Nashville, TN, USA
| | - Fei Gao
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
| |
Collapse
|
5
|
Quan M, Wang Q, Qin W, Wang W, Li F, Zhao T, Li T, Qiu Q, Cao S, Wang S, Wang Y, Jin H, Zhou A, Fang J, Jia L, Jia J. Shared and unique effects of ApoEε4 and pathogenic gene mutation on cognition and imaging in preclinical familial Alzheimer's disease. Alzheimers Res Ther 2023; 15:40. [PMID: 36850008 PMCID: PMC9972804 DOI: 10.1186/s13195-023-01192-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Accepted: 02/13/2023] [Indexed: 03/01/2023]
Abstract
BACKGROUND Neuropsychology and imaging changes have been reported in the preclinical stage of familial Alzheimer's disease (FAD). This study investigated the effects of APOEε4 and known pathogenic gene mutation on different cognitive domains and circuit imaging markers in preclinical FAD. METHODS One hundred thirty-nine asymptomatic subjects in FAD families, including 26 APOEε4 carriers, 17 APP and 20 PS1 mutation carriers, and 76 control subjects, went through a series of neuropsychological tests and MRI scanning. Test scores and imaging measures including volumes, diffusion indices, and functional connectivity (FC) of frontostriatal and hippocampus to posterior cingulate cortex pathways were compared between groups and analyzed for correlation. RESULTS Compared with controls, the APOEε4 group showed increased hippocampal volume and decreased FC of fronto-caudate pathway. The APP group showed increased recall scores in auditory verbal learning test, decreased fiber number, and increased radial diffusivity and FC of frontostriatal pathway. All three genetic groups showed decreased fractional anisotropy of hippocampus to posterior cingulate cortex pathway. These neuropsychological and imaging measures were able to discriminate genetic groups from controls, with areas under the curve from 0.733 to 0.837. Circuit imaging measures are differentially associated with scores in various cognitive scales in control and genetic groups. CONCLUSIONS There are neuropsychological and imaging changes in the preclinical stage of FAD, some of which are shared by APOEε4 and known pathogenic gene mutation, while some are unique to different genetic groups. These findings are helpful for the early identification of Alzheimer's disease and for developing generalized and individualized prevention and intervention strategies.
Collapse
Affiliation(s)
- Meina Quan
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Qi Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Wei Qin
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Wei Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Fangyu Li
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Tan Zhao
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China
| | - Tingting Li
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Qiongqiong Qiu
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Shuman Cao
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Shiyuan Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Yan Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Hongmei Jin
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Aihong Zhou
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Jiliang Fang
- grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
| | - Longfei Jia
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Jianping Jia
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. .,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China. .,Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China. .,Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China. .,Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China. .,Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.
| |
Collapse
|
6
|
Yu T, Li D, Zeng Z, Xu X, Zhang H, Wu J, Song W, Zhu H. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration. Front Genet 2022; 13:821826. [PMID: 35664320 PMCID: PMC9161087 DOI: 10.3389/fgene.2022.821826] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Accepted: 04/04/2022] [Indexed: 01/01/2023] Open
Abstract
Background: Previous studies have verified that Inscuteable Spindle Orientation Adaptor Protein (INSC) can regulate cell proliferation and differentiation in the developing nervous system. It also plays an important role in spindle orientation during mitosis and asymmetric division of fibroblasts and participates in the process of stratification of the squamous epithelium. The role and potential mechanism of INSC in the development of colonic adenocarcinoma (COAD) have not been fully understood. This study aimed at exploring the prognostic value of INSC in COAD and the correlation of its expression with immune infiltration.Methods: The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) project, Gene Expression Profiling Interactive Analysis (GEPIA), and Gene Expression Omnibus (GEO) database were used to analyze the expression of INSC in COAD. The INSC protein expression level was analyzed by immunohistochemistry staining and the Human Protein Atlas (HPA) database. The diagnostic and prognostic values of INSC in COAD patients were analyzed using receiver operating characteristic (ROC) and Kaplan–Meier (KM) survival curves. In order to understand whether INSC is an independent prognostic factor, we used univariable and multivariate Cox analyses to analyze INSC expression and several clinical characteristics with survival. We use STRING analysis to find INSC-related proteins and related biological events analyzed by Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. At last, GEPIA and the Tumor Immune Estimation Resource (TIMER) were employed to explore the relationship between INSC and immune infiltrates and its marker gene set.Results: INSC was lower expressed in COAD tissues than in normal colon tissues, which was correlated with tumor stage. Patients with lower expression of INSC had shorter overall survival (OS). Moreover, univariable Cox analysis demonstrated that high expression of INSC was an independent prognostic factor for COAD. ROC analysis showed INSC was an accurate marker for identifying tumors from normal colon tissue, and the AUC of the curve was 0.923. Significant GO term analysis by GSEA showed that genes correlated with INSC were found to be enriched in several immune-related pathways. Specifically, INSC expression showed significant negative correlations with infiltration levels of B cells, CD4+ T cells, macrophages, DCs, and their marker sets in COAD.Conclusion: INSC was provided with prognostic value in COAD and related to immune invasion.
Collapse
Affiliation(s)
- Tao Yu
- Department of Oncology, Integrated Chinese and Western Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- *Correspondence: Tao Yu, ; Hua Zhu,
| | - Dan Li
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China
| | - Zhi Zeng
- Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China
| | - Xu Xu
- Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China
| | - Haiming Zhang
- Department of Oncology, Integrated Chinese and Western Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jie Wu
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China
| | - Wei Song
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China
| | - Hua Zhu
- Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China
- *Correspondence: Tao Yu, ; Hua Zhu,
| |
Collapse
|